Clinical trial / 2009
In patients with atopic dermatitis, consuming mare's milk significantly reduced mean SCORAD scores at 12 weeks.
A double-blind, placebo-controlled crossover trial evaluated the consumption of 250 ml mare's milk or placebo for 16 weeks in 23 patients with atopic dermatitis. The mean SCORAD value decreased from 30.1 to 25.3 after 12 weeks (P<0.05) and to 26.7 after 16 weeks (P<0.1) during the mare's milk period. In a subgroup of 7 patients, the SCORAD index and pruritus decreased by 30% (P<0.01), accompanied by an increase in faecal bifidobacteria from 4.6% to 11.9% of eubacteria (P<0.05). Immunological parameters remained unchanged, with the exception of C-reactive protein.
- Study type
- Double-blind, placebo-controlled crossover trial
- Who was studied
- 23 patients with atopic dermatitis (17 females, 6 males)
- What was measured
- Severity Scoring of Atopic Dermatitis (SCORAD), faecal microbiota, and immunological parameters
THE PAPER
Dietetic effects of oral intervention with mare's milk on the Severity Scoring of Atopic Dermatitis, on faecal microbiota and on immunological parameters in patients with atopic dermatitis.
Foekel C, Schubert R, Kaatz M, Schmidt I, Bauer A, Hipler UC, Vogelsang H, Rabe K, Jahreis G. Int J Food Sci Nutr, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.